Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience
Date
2007Author
Hofman, Michael S.Constantinidou, Anastasia
Acland, Katharine M.
Healy, Ciaran
Harries, Mark
O'Doherty, M.
Source
Nuclear medicine communicationsVolume
28Issue
12Pages
902-906Google Scholar check
Keyword(s):
Metadata
Show full item recordAbstract
The management of metastatic melanoma remains challenging with only modest response rates to chemotherapy but the need to identify the best re-staging techniques remains paramount. This study evaluates our early experience in the use of FDG PET-CT in the assessment of early response to chemotherapy in metastatic melanoma. © 2007 Lippincott Williams & Wilkins, Inc.